Induction of remission in hepatocellular carcinoma: A comparison of VP 16 with adriamycin
β Scribed by W. M. Melia; P. J. Johnson; Roger Williams
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 511 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Forty-six previously untreated patients with acute nonlymphocytic leukemia were treated with a remission induction regimen consisting of three daily doses of Adriamycin (30 mg/m2/day) and a ten-day continuous infusion of cytosine arabinoside (ara C) (100 mg/m2/day). The overall remission rate was 72
One hundred twenty-two patients with advanced adenocarcinoma of the breast were randomized to receive adriamycin (AD) alone or a combination of VP-16 plus lower dose adriamycin (VAD). The patients were stratified to good and poor risk. The starting dose (day 1) of AD was 60 mg/m2 for good risk and 4
## Abstract Three therapeutic regimens (6βhr intervals for 6 doses daily for 3 days, and a single infusion) utilizing the same total dose of adriamycin for the induction of remission in children with lateβstage acute leukemia were evaluated in 150 patients. Complete remission rates were 15%, 28%, a